Orlistat: how the fat blocker works for weight loss

24 Mar

Orlistat has been on the market since 1999, but is often overshadowed by newer GLP-1 drugs such as semaglutide and tirzepatide. That’s a shame, because the mechanism behind orlistat is fundamentally different — and for the right person, it can still be a valuable tool. The substance is available in two variants on the Swedish market: prescription Xenical (120 mg) and non-prescription Alli (60 mg). Here we go through exactly how orlistat works, what results you can expect, which side effects are most common and how the preparation compares to today’s GLP-1-based alternatives.

How does orlistat block fat absorption in the body?

Orlistat acts locally in the gastrointestinal tract, not via the central nervous system. The substance inhibits the enzyme gastric and pancreatic lipase — the enzymes that break down dietary fat (triglycerides) into free fatty acids and monoglycerides that the body can absorb. When these enzymes are blocked, some of the fat you eat passes straight through the intestines without being absorbed.

In the standard dose of 120 mg (Xenical), taken three times daily with meals, approximately 30% of dietary fat is blocked. This means that if you eat a meal with 30 grams of fat, approximately 21 grams are absorbed while 9 grams pass through the body unaffected. The calorie deficit created in this way is typically around 150–200 kcal per day, depending on fat intake.

What happens to the fat that is not absorbed?

The unabsorbed fat ends up in the large intestine and leaves the body via the feces. This is precisely what causes most of orlistat’s known side effects — fatty, oily stools, frequent toilet visits and, in the worst case, uncontrolled fat leakage. The side effects are directly proportional to the fat intake: the more fat you eat, the more discomfort. In a sense, orlistat acts as a built-in “punishment mechanism” that forces users to reduce their fat intake, which reinforces the overall calorie reduction.

The body partially adapts after the first 2–4 weeks, but the side effects never completely disappear as long as the treatment continues and the fat intake exceeds 15–20 grams per meal. Many users report that they learn to adapt their diet within the first month — and it is precisely this behavioral adaptation that makes orlistat unique among weight loss drugs. No other substance gives such direct and immediate feedback on dietary choices as orlistat does.

An often overlooked aspect is that orlistat also affects the absorption of fat-soluble vitamins and certain drugs. Birth control pills, levothyroxine and blood thinners may reduce absorption when used simultaneously. Therefore, it is recommended to take other medicines at least two hours before or after the orlistat dose — a detail that not all doctors inform about when prescribing.

Orlistat dosage and clinical results in weight loss

Orlistat comes in two strengths, and the choice depends on whether you have a prescription or not. The table below summarizes dosage and expected results based on clinical data (1998–2023):

|Preparation|Dose|Intake|Average weight loss (1 year)|Proportion losing >5%|

|Alli (over the counter)|60 mg|3 times/day with meals|3–4% of body weight|about 35–40%|

|Xenical (prescription)|120 mg|3 times/day with meals|5–7% of body weight|about 50–55%|

The figures above always include a calorie-reduced diet — orlistat was never tested without dietary intervention. A person weighing 95 kg can therefore expect to lose approximately 5-7 kg during the first year with Xenical, provided that the diet is adjusted in parallel. It may sound modest compared to semaglutide’s 10-15%, but orlistat has a major advantage: it does not affect the brain, appetite or hormones.

The comparison between orlistat and other weight loss methods depends on which mechanism you prefer. Want to see a broader overview? Read our comparison between injections and tablets for weight loss where all options are pitted against each other.

The treatment period with orlistat is recommended to be at least 12 weeks before evaluating the effect. If the weight loss has not reached at least 5% after 12 weeks on the Xenical dose, the treatment should be reconsidered together with the doctor. Long-term studies, including the four-year XENDOS study with over 3,000 participants, show that the effect is maintained during 2-4 years of treatment with some tapering of weight loss after the first year. An interesting finding in XENDOS was that the orlistat group had a 37% lower risk of developing type 2 diabetes compared to placebo — a bonus that goes beyond mere weight loss.

Orlistat side effects — what you can really expect

The side effect profile of orlistat is radically different from GLP-1 drugs. Where semaglutide causes nausea, vomiting and constipation, orlistat causes gastrointestinal problems of a completely different nature. Here are the most common side effects ranked by frequency:

• Oily and greasy stools — occurs in 15-30% of users, most pronounced in the first few weeks. Directly linked to fat intake in the diet.

• Increased gas formation with fatty leakage — reported by about 20% and often described as the most socially awkward side effect. Decreases if fat intake is kept below 20 g per meal.

• Frequent and urgent toilet visits — about 10–15% feel that they need access to the toilet quickly after meals, especially after high-fat lunches.

• Lack of fat-soluble vitamins (A, D, E, K) — long-term users should supplement with a multivitamin preparation taken at least 2 hours before or after the orlistat dose.

• Headache and abdominal pain — less common (5-8%) and often transient.

The positive side of the side effect profile is that it works as a natural behavioral tool. Most users report that they quickly learn to identify which meals trigger discomfort, and adjust their diet accordingly. In practice, this leads to a double effect: reduced fat intake via the drug plus reduced fat intake via behavioral change. Studies from 2019 show that on average, orlistat users reduce their daily fat intake by 20-25% compared to baseline — a change that persists in many even after treatment ends, precisely because the link between high-fat foods and discomfort has been learned.

Orlistat vs GLP-1 drugs — which route is best for you?

Comparing orlistat to semaglutide or tirzepatid is like comparing a chainsaw to a scalpel — both cut, but the mechanisms and precision are completely different. GLP-1 drugs act centrally in the brain, reduce appetite hormonally and produce an average of 2-3 times greater weight loss. Orlistat acts locally in the intestine, does not affect hunger and produces a more modest effect.

When is orlistat a better choice than semaglutide?

There are specific situations where orlistat may actually be preferable. Patients who do not tolerate GLP-1 side effects (persistent nausea, vomiting, pancreatitis risk) may benefit from orlistat’s completely different side effect profile. People with type 2 diabetes who are already on other GLP-1 drugs for blood sugar control cannot always add another GLP-1 agonist, while orlistat is combined without pharmacological interaction.

Cost is another factor that should not be underestimated. Alli is available without a prescription for around SEK 300–500 per monthly pack. Ozempic or Wegovy costs SEK 1,500–3,000 per month without subsidy, and availability varies widely depending on region and pharmacy stock. For those who need an easier, cheaper first step, orlistat can act as a bridge while waiting for GLP-1 treatment or as an adjunct to lifestyle changes.

The availability also speaks to orlistat’s advantage. Alli can be bought directly from a pharmacy without a doctor’s contact, which makes the threshold significantly lower. GLP-1 drugs require a prescription, often a specialist and sometimes a longer investigation. For those who want to start their weight loss journey already tomorrow, orlistat offers an immediate effort with no waiting time.

Looking for other options that can support fat burning? Check out our review of the best fat burners 2026 where orlistat is included in the comparison. What orlistat lacks in pure weight loss effect, it makes up for in part with its long safety profile — 25+ years of clinical use — and by not interfering with the body’s hormonal system. The decision should always be made together with a doctor, based on your complete medical history, current BMI and personal preferences regarding form of treatment.

.entry-content